What do the study numbers mean for me?

A dummy treatment for comparison is called a placebo; in the study below, it was a shot without semaglutide.

STEP 1 tested semaglutide injections in adults without diabetes who had obesity, meaning substantial excess body weight, or overweight with a related health problem.

The study enrolled 1,961 adults, who also had lifestyle support and regular visits.

The medicine's maker funded this study.

Over 68 weeks in STEP 1, the semaglutide group had average weight loss of 14.9%; the dummy shot group averaged 2.4%.

That is a share of starting body weight, rather than a number of pounds everyone lost.

An average brings the group's results together; people in that group had different results.

If an online offer points to study numbers, ask whether the exact product in the offer was tested.

Compounded drugs are medicines prepared to order.

In the United States, medicine review is the work of the Food and Drug Administration (FDA). As of September 2026, it warned against claims that a made-to-order drug had been proven to match an approved product's results. Here, results means how well the treatment works. FDA also warned against claiming that a made-to-order drug had been reviewed for safety and benefit when it had not.

A later part of STEP 1 followed 327 people after treatment ended.

At the check a year after stopping, the group had put back about two-thirds of its lost weight.

This finding describes the study group; it cannot set the length of treatment for an individual.